A new sublingual formulation of apomorphine in the treatment of patients with Parkinson's disease
暂无分享,去创建一个
M. Danhof | T. van Laar | R. Roos | K. Roon | C. Neef | Roos | tC ‘T. van Laar | “M Neef | K. I. Danhof | C. RoonR.A. | disad-
[1] E. Tolosa,et al. Treatment of Parkinson's disease with aporphines. Possible role of growth hormone. , 1976, The New England journal of medicine.
[2] A. Eschalier,et al. Relation between clinical efficacy and pharmacokinetic parameters after sublingual apomorphine in Parkinson's disease. , 1993, Clinical neuropharmacology.
[3] T. van Laar,et al. Rectal apomorphine: a new treatment modality in Parkinson's disease. , 1992, Journal of neurology, neurosurgery, and psychiatry.
[4] A J Lees,et al. Dopamine agonists in Parkinson's disease: a look at apomorphine , 1993, Fundamental & clinical pharmacology.
[5] J. Nutt,et al. Absorption of apomorphine by various routes in parkinsonism , 1991, Movement disorders : official journal of the Movement Disorder Society.
[6] F. Durif,et al. Efficacy of sublingual apomorphine in Parkinson's disease. , 1990, Journal of neurology, neurosurgery, and psychiatry.
[7] R. Roos,et al. A double-blind study of the efficacy of apomorphine and its assessment in ‘off’-periods in Parkinson's disease , 1993, Clinical Neurology and Neurosurgery.
[8] M. Landi,et al. Determination of apomorphine in rat plasma and brain by high-performance liquid chromatography with electrochemical detection. , 1985, Journal of chromatography.
[9] A. Lees,et al. Sublingual apomorphine in the treatment of Parkinson's disease complicated by motor fluctuations. , 1991, Clinical neuropharmacology.
[10] O. Rascol,et al. Sublingual apomorphine and Parkinson's disease. , 1989, Journal of neurology, neurosurgery, and psychiatry.
[11] T. van Laar,et al. Intranasal apomorphine in parkinsonian on-off fluctuations. , 1992, Archives of neurology.
[12] P. Panegyres,et al. Sublingual apomorphine solution in Parkinson's disease , 1991, The Medical journal of Australia.
[13] C. Edwards. Letter: Follow-up in tuberculosis. , 1974, Lancet.
[14] A. Lees,et al. Subcutaneous apomorphine in the treatment of Parkinson's disease. , 1990, Journal of neurology, neurosurgery, and psychiatry.
[15] Gualano,et al. Sublingual apomorphine in Parkinson's disease: a clinical and pharmacokinetic study. , 1991, Clinical neuropharmacology.